450. Electron microscopy revealed a coronary EG of 300 nm, reduced to 20 nm after heparinase. Cultured endothelial cells possessed an EG of 20 nm to begin with. Conclusions: Albumin induces greater endothelial shear stress than HES, despite lower viscosity, provided the EG contains negative groups. HES 450 causes some NO-mediated dilatation via even a rudimentary EG. Cultured endothelial cells express only a rudimentary glycocalyx, limiting their usefulness as a model system.
Introduction
The physiological importance of the endothelial glycocalyx (EG) had been ignored for many years. Modern preparation and staining techniques, however, have revealed a glycocalyx with a relevant thickness ranging from 0.3 to more than 1.0 m [1] [2] [3] [4] [5] throughout the vascular bed. This EG consists of extracellular domains of molecules like transmembrane syndecans and membrane-bound glypicans that both contain many covalently bound, negatively charged heparan sulfate and chondroitin sulfate groups [6] . The observation of intercalated plasma components, mainly albumin, led to the modern concept of the endothelial surface layer (ESL) which denies access of blood cells and large molecules to the en-dothelial surface [6] [7] [8] [9] and, under physiological circumstances, likely covers adhesion molecules like selectins and integrins [10, 11] , preventing pathological adhesiveness of the vascular wall [12] . Consequently, several important properties are to be attributed to the EG: it is involved in inflammatory processes and immune reactions [13, 14] and has been identified as a competent barrier against extravasation of fluids and colloids [4, 8, [15] [16] [17] . Other work suggested that the EG should play a key role in mediating shear stress to the endothelial surface and in triggering the production of vasoregulatory agents, mainly nitric oxide (NO) [18] [19] [20] [21] [22] [23] .
While the intracellular signaling pathway of shear stress-induced vasodilatation is well explored [24] , the transduction of this stress to the endothelial surface remains rather unclear. The production of NO, catalyzed by endothelial NO synthase, responds, according to experiments with monolayers of endothelial cells from human umbilical vein (HUVEC) and bovine aorta, in a biphasic manner to shear stress [18, 19, 21] . An initial rapid production phase (G protein and Ca 2+ -dependent, influenced by rate of change of shear more than by the absolute shear level) is followed by a phase of lower production of NO (G protein and Ca 2+ -independent, influenced by the absolute shear level [21] ).
Most of the studies dealing with NO release induced by shear stress, however, are limited by the employed experimental model, i.e., cultured endothelial cells, presumably possessing only a rudimentary EG not comparable to the endothelial cell surface in vivo [18, 19] . Additionally, this model does not deliver any functional data to quantify the effect of an applied shear stress on vascular flow, the main objective of releasing NO. Also, the ability of specified colloids to transmit shear stress to the endothelial cells via the individually generated ESL has not been compared quantitatively in situ.
In recent work on the isolated guinea pig heart, we substantiated that the role of colloids concerning vascular permeability depends predominantly on their ability to interact with the EG to form an ESL [8, 17] . We observed an impressive sealing effect of human albumin during perfusion under constant flow, a mode in which the coronary system was able to alleviate shear stress by dilating.
The aim of the current study was to compare the functional impact of albumin and artificial colloids on vasodilatation induced by shear stress in the whole organ model. Due to its interaction with the EG we expected albumin to be more effective than artificial alternatives. In order to augment shear stress-induced vasodilatation, constant pressure perfusion of the coronary system was implemented. Because coronary endothelial cells in situ possess a glycocalyx of some 200-300 nm thickness [4, 8, 16] , we additionally checked for the presence of an EG in confluent, cultured HUVECs, one of the most common 'artificial' models of the intravascular surface.
Methods

Heart Preparation
Guinea pig hearts were isolated and perfused in a modified Langendorff mode at constant perfusion pressure of 80 cm H 2 O and at 37 ° C with modified Krebs-Henseleit buffer (KHB) as described elsewhere [4, 8, 25] .
Experimental Protocols
Experimental protocols are outlined in figure 1 .
Control Groups
Time-matched vehicle control values were measured during infusion of 1/3 volume of 0.9% saline ('control' group), after additional pretreatment with heparinase ('control heparinase' group), or during additional application of nitro-L -arginine (NO-L -Ag), a substance known to block the endothelial NO synthase ('control NO-L -Ag' group; n = 5 each).
Colloid Groups with Intact Glycocalyx
Three different, clinically relevant colloids were added to KHB (1/3 volume via the aortic feed line): 5% human albumin, 6% hydroxyethyl starch (HES) 200, and 6% HES 450. The resulting groups were termed 'albumin', 'HES 200' and 'HES 450' (n = 5, 6 and 5, respectively).
Colloid Groups after Heparinase Pretreatment, NO-L -Ag Application, or Combined Intervention
We performed the same experiments as before, but after pretreatment of hearts with heparinase ('albumin + H', 'HES 200 + H' and 'HES 450 + H' groups; n = 5, 6 and 5, respectively). In 'albumin + NO-L -Ag' and 'HES 450 + NO-L -Ag' groups (n = 8 and 5, respectively), we infused NO-L -Ag during replacement of 1/3 volume of KHB with 5% human albumin or 6% HES 450 (phase III). In two further groups, hearts pretreated with heparinase (phase IIA) received NO-L -Ag in addition to 1/3 volume 5% human albumin or HES 450 ('albumin + NO-L -Ag + H' and 'HES 450 + NO-L -Ag + H'; n = 5 each).
Electron Microscopy of Hearts
Two additional hearts in each group, treated in the same way as described in the respective protocols, were prepared for electron microscopy. This was performed in modification of the method of Vogel et al. [26] , as described elsewhere [8, 16] and relied primarily on stabilization of the glycocalyx with the polyvalent cation lanthanum (La 3+ ), which binds to the negative charges (heparan and chondroitin sulfates). Accordingly, the glyceal structure visualized in this manner does not entirely reflect the natural state, presumably appearing more orderly and more rigid that in vivo. However, it allows a quantitative estimation of the thickness of the layer.
During electron-microscopic examination (Philips CM 10), whole capillary profiles were photographed systematically so that all capillaries in a section were photographed with the exception of those which were collapsed. This is justified because only capillaries with an open lumen provide a guarantee of having been perfused and uniformly stained with the glycocalyx tracer. Only in these is it possible to assess the thickness of the layer. The photographed capillaries presented here reflect the general and fairly uniform changes seen in the respective perfusion groups. Black and white images of approximately 50 capillaries of at least two hearts of each group were compiled. Electron-microscopic views were assessed qualitatively only.
Cultivation and Electron Microscopy of HUVEC
Endothelial cells freshly isolated from human umbilical veins (2nd passage) were seeded onto -slides (IBIDI, Munich, Germany) and grown to three stages of maturity: nonconfluent, confluent and onset of capillarization. HUVEC monolayers (n = 5) were prepared for electron microscopy in a manner comparable to that described above for the hearts at the end of the experimental protocols.
Statistical Analysis
All data are presented as mean 8 SD, with n indicating the number of experiments. Comparisons were made using analysis of variance. Post hoc testing was performed using the StudentNewman-Keuls method for multiple comparisons. A p value less than 0.05 was considered to be significant. Table 1 provides an overall listing of coronary flow during control conditions (1/3 volume of 0.9% saline added to the Krebs-Henseleit perfusate). In the absence of any further intervention, there was no time-dependent alteration in coronary vascular tone over the 20-min period of observation. While heparinase pretreatment did not cause any measurable change in coronary flow, a slight decrease developed with time during NO-L -Ag infusion, indicating that this intervention is able to increase basal vascular tone even in a colloid-free perfusion mode. The effect was significant from the 6th minute of application onward.
Results
Coronary flow did not change in the saline group, which serves as the vehicle control to disclose any effects arising from a dilution of the KHB by As can be seen in figure 3 a, the increase in flow caused by albumin was diminished by NO-L -Ag infusion or heparinase pretreatment, or by both interventions when performed in one and the same heart. The 20-min values were 6.23 8 0.68, 5.38 8 1.31 and 5.11 8 1.03 ml/min/g for the albumin + NO-L -Ag, albumin + H, and albumin + NO-L -Ag + H groups, respectively. Thus, while 10 M NO-L -Ag by itself did not cause full inhibition of the albumin-induced dilatation, the values after heparinase were not significantly higher than in the time-matched control heparinase group ( table 1 ) . Also, the effect of NO-L -Ag was not additive to that of heparinase in the case of albumin. In contrast, during infusion of HES 450, blocking formation of NO by application of NO-L -Ag, but not stripping away the heparan sulfates from the EG significantly suppressed the coronary flow rate ( fig. 3 b) . Table 2 provides dynamic viscosities and colloid osmotic pressures of the respective perfusates. As can be seen in table 2 and figure 2 , colloid-induced, flow-dependent coronary dilatation does not correlate with dynamic viscosity when colloids of a different chemical nature are compared. When perfusing with KHB plus albumin the dynamic viscosity is comparable to that pertaining to colloid-free perfusion, but flow was doubled. In contrast, the viscosity after adding 1/3 volume 6% HES 450 is almost twice as high as that of KHB, while the flow remained unchanged. Again, the flow in the HES 450 + NO-L -Ag group was identical to that observed after 20 min in the control NO-L -Ag group (compare fig. 3 b and table 1 The colloid osmotic pressure of perfusate containing HES 200 is larger than that of the smaller molecular weight albumin or the higher molecular weight HES 450 ( table 2 ) . However, the latter is still comparable to that of albumin, despite the approximately 6-to 7-fold difference in average molecular weight (66 vs. 450 kDa). The flow effects observed in figure 2 did not correlate with these colloid osmotic pressures.
Electron microscopy revealed an EG with a thickness of approximately 0.2-0.3 m in nonpretreated hearts and in hearts treated with NO-L -Ag, both in capillary vessels as well as in arteries (see fig. 4 ). This in situ result stands in clear contrast to the situation on a nonpretreated monolayer of HUVEC (2nd passage cells), stained by the same technique as were the hearts ( fig. 4 b) . There is no relevant EG on HUVEC, the measured thickness being about 20 nm. The same dimension was observed, irrespective of the state of confluence of the cultures (results not shown).
Heparinase pretreatment, at first sight, led to a destruction of the EG ( fig. 5 ) . However, at a higher magnification, a rudimentary glycocalyx could be identified in some parts of the vasculature, even after enzymatic digestion ( fig. 5 ). This possibly represents the remaining syndecan and glypican scaffold. Colloid osmotic pressure determined with Oncometer BMT 923 (BMT Messtechnik, Berlin, Germany) at 37° C. Kinematic viscosity measured at 37° C with a Viscosimeter Type D60L (Lauda Dr. R. Wobser, Lauda-Königshofen, Germany), dynamic (absolute) viscosity calculated as: dynamic viscosity (cP) = kinematic viscosity (cSt) ! density (g/ml).
a KHB augmented by 1/3 volume of the respective solution.
Discussion
The endothelial surface is covered by a glycocalyx consisting of glycoproteins, proteoglycans and associated glycosaminoglycan (GAG) side chains [6, 19] . The main type of GAG on the endothelial cell surface are heparan sulfates, comprising up to 90% of the GAG pool [27] . Their function as signal transduction molecules has been extensively studied [28] . Heparan sulfate proteoglycans can be divided into three different groups on the basis of the respective protein backbone: syndecans, glypicans and perlecans [19] . The largest group on the endothelial surface, the syndecans, are the only heparan sulfate proteoglycans that penetrate the cytoplasm to interact with the cytoskeleton [29] . They have highly variable extracellular domains and highly conserved intracellular phosphorylation sites [30] . It is assumed that the syndecans transduce shear stress into cellular signals [31, 32] .
In the isolated perfused organ model, we were able to demonstrate that albumin, in contrast to artificial colloids, leads to an impressive, significant increase in coronary flow in the constant pressure perfusion mode. This phenomenon seems to result largely from shear stress transmitted via the glycocalyx on the endothelial surface. At least in the guinea pig heart, this leads chiefly to the generation of NO, since it was possible to inhibit the flowdependent dilatation by blocking the NO synthase almost as well as by stripping away the main part of the glycocalyx. Interestingly, these two interventions were not additive in the case of albumin.
Maximal coronary flow that can be achieved in these heart preparations at 80 cm H 2 O perfusion pressure is about 25 ml/min/g [33, 34] . Thus, the flow increases induced by shear stress seen here were quite moderate. Whether the enhancement of basal NO production via shear stress alters coronary responses to other vasodilators (endothelium and nonendothelium dependent) was not tested in this study. Both desensitization and augmentation appear to be valid options.
Pertinently, the dilatation induced by albumin did not quite reach a steady state during our observation time of 20 min, likely due to a positive feedback mechanism: shear stress leads to NO-mediated vasodilatation, whereupon the coronary flow increases; consequently, the shear stress increases again somewhat. In this context, attention must be drawn to the fact that both, the mode of perfusion (constant pressure) and the style of preparation (incompetent mitral valve precluding the performance of any pressure-volume work), were chosen to augment such feedback possibilities. Accordingly, during constant flow perfusion supplementing perfusate with albumin elicits only a small, self-limiting drop in steady-state coronary perfusion pressure, i.e., due to negative feedback only a limited vasodilatory response is to be observed [8] .
The isolated perfused heart as prepared here (Langendorff mode) per definition does not perform any pressurevolume work. Nevertheless, coronary flow is under a certain degree of metabolic control. Changes in coronary flow, of course, change oxygen delivery to the heart preparation. Thus, albumin-induced dilatation will be counteracted to some extent by an autoregulatory increase in vascular tone, while flow reduction due to perfusion with a medium of a higher viscosity (KHB + 1/3 volume HES 450) will elicit some reactive metabolic dilatation. However, from previous work it is known that delivery of oxygen via perfusates without hemoglobin does not limit oxygen consumption. In fact, there is considerable 'luxury' perfusion [33, 35] . The effects of altered supply on coronary reaction are, therefore, very much attenuated and have not been considered further in the present study. Since the PO 2 of all perfusates was identical (approximately 400 mm Hg), metabolic regulation should not have elicited flows different from those observed with KHB + vehicle (control groups receiving 0.9% saline).
The reason why albumin causes an effect far larger than that observed during infusion of artificial colloids could relate to a specific interaction of the natural colloid with the glycocalyx. By virtue of its amphiphilic nature, i.e., the presence of both negatively and positively charged groups in the molecule, albumin forms a complete ESL [2, 4, 8, 15] . In contrast, the glycocalyx represents an exclusion zone for large neutral and anionic molecules like dextrans 6 70 kDa [36, 37] and it may be expected that other large molecules carrying an exclusively negative charge, such as HES, also do not interact well with an intact EG. Accordingly, an albumin-containing perfusate should 'hook' into this structure, transmitting shear stress to the vessel wall, while artificial colloids like HES, figuratively speaking, brush only against the top of the glycocalyx molecules [38] . Such a difference is reflected by the similarity in intravascular distribution spaces of HES and red blood cells in vivo, as opposed to those tracers binding to albumin [39, 40] . This interpretation is also in line with our previous work concerning the barrier function of the EG [4, 8, 17] , which is also overproportionally enhanced by albumin versus HES [8] . Owing to the different quality of the ESL, it is understandable why there was only an insignificant mean increase in coronary flow in the HES groups in comparison to perfusion with colloid-free buffer, and why no simple relationship existed to dynamic viscosity of the various perfusates.
Notwithstanding, from comparing the coronary flows after heparinase pretreatment and during NO-L -Ag application, it can be derived that colloids are able to mediate some shear stress to the vessel wall, even after most of the negative charges have been stripped from the EG with heparinase. The difference was significant in the experiments with KHB augmented with HES 450. As demonstrated previously, heparinase is an enzyme specific for heparan sulfates and, therefore, has the ability to alter thickness [1, 3, 4] and barrier function [4, 17, 34, 41] of the glycocalyx. However, as revealed by electron microscopy at a high magnification in this work, small regions of glycocalyx remain also after heparinase pretreatment, likely representing a scaffold of syndecans and glypicans minus side chains. Obviously, HES molecules with the high molecular weight of 450 kDa are big enough to interact mechanically with a rudimentary glycocalyx, causing some increase in coronary flow sensitive to inhibition of the NO synthase.
Surprisingly, in the presence of NO-L -Ag, the flow with perfusate containing HES 450 did not differ from that of control hearts perfused with NO-L -Ag (see fig. 3 ; table 1 ), despite the different perfusate viscosity. Since NO-L -Ag is expected to inhibit both, stimulated and basal NO production, some residual dilatory mechanism must still be active for HES 450 in the absence of NO generation. The same conclusion as for HES 450 may be drawn in the case of albumin. Here too, NO-L -Ag did not fully inhibit the rise in coronary flow induced by albumin versus control. These phenomena could relate to induction of endothelium-derived hyperpolarizing factor or prostacyclin by shear stress.
Numerous studies have examined shear stress-mediated actions on cultured endothelial cells, but only few even considered the relationship between the EG and shear stress-induced effects. For example, Florian et al. [19] stated, due to qualitative staining of heparan sulfate via a fluorescent antibody in a bovine aortic endothelial cell monolayer, that they were dealing with an EG in their model. Ueda et al. [39] delivered electron-microscopic pictures of the EG in a comparable model after staining with ruthenium red. The resulting absolute thickness is not quantified, but according to the presented scale in their figures, we would estimate it to be less than 50 nm. In contrast, by stabilizing the EG with La 3+ during fixation we measured a thickness of at least 300 nm for the healthy, colloid-free glycocalyx, as also reported previously [4, 8, 14, 16] . On the basis of our electron-microscopic images, the EG of cultured HUVEC should, at best, be comparable to that established after heparinase pretreatment of coronary vascular endothelial cells in situ. Consequently, measuring release of NO induced by shear stress with cultured cells can, in no way, reflect normal behavior of an intact EG. Release of NO due to shear stress in this setting could represent an interaction of the perfusate with the rudimentary glycocalyx, or it could result from direct deformation of the endothelial cell membrane by the flowing buffer. In any case, the cultured monolayer seems an extremely poor model of the conditions in vivo, at least concerning the physiological impact of the EG in its capacity to form a competent ESL.
The discrepancy between cultured endothelial cells and the situation in vivo becomes even greater when considering a shortcoming of our perfusion model, namely the absence of plasma constituents possibly augmenting formation of the ESL by albumin. Numerous studies have suggested that albumin alone is not as effective in reducing vascular permeability as plasma and serum [42] . The same may hold true with respect to the magnitude of shear stress-mediated coronary dilatation.
In conclusion, the present work highlights the value of the physiological plasma component albumin for developing an ESL and thereby eliciting strong shear stress dependency of vascular dilatation. This interaction should help to maintain basal nutritive blood flow, possibly by strengthening natural vasomotion and reducing the likelihood of capillaries having low or no perfusion. The results thus suggest a need for reconsidering the widespread clinical use of nonphysiological substances as substitutes of plasma colloids. At least in critically ill patients, infusion of albumin would seem the better therapeutic choice.
